We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+13.63%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$48.3B
AUM Growth
+$4.2B
Cap. Flow
-$749M
Cap. Flow %
-1.55%
Top 10 Hldgs %
25.22%
Holding
973
New
114
Increased
273
Reduced
385
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 25.57%
2 Healthcare 16.39%
3 Financials 11.55%
4 Consumer Discretionary 10.38%
5 Industrials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKC icon
476
McCormick & Company Non-Voting
MKC
$14.2B
$16.7M 0.03%
244,130
-5,500
-2% -$360K
A icon
477
Agilent Technologies
A
$41.2B
$16.7M 0.03%
119,994
-76,914
-39% -$9.15M
CHD icon
478
Church & Dwight Co
CHD
$24.5B
$16.6M 0.03%
176,024
+13,425
+8% +$1.23M
OMC icon
479
Omnicom Group
OMC
$23.4B
$16.6M 0.03%
192,278
-4,200
-2% -$331K
ULTA icon
480
Ulta Beauty
ULTA
$24.3B
$16.6M 0.03%
33,852
-27,625
-45% -$11.7M
NRG icon
481
NRG Energy
NRG
$24.8B
$16.5M 0.03%
319,252
-496,000
-61% -$22.4M
ALB icon
482
Albemarle
ALB
$15.5B
$16.5M 0.03%
113,979
-2,700
-2% -$371K
PRAX icon
483
Praxis Precision Medicines
PRAX
$10.1B
$16.5M 0.03%
738,666
+153,333
+26% +$2.76M
CMS icon
484
CMS Energy
CMS
$22.3B
$16.5M 0.03%
+283,361
New +$15.8M
BR icon
485
Broadridge
BR
$19B
$16.3M 0.03%
79,300
-38,100
-32% -$7.03M
ABEO icon
486
Abeona Therapeutics
ABEO
$413M
$16.3M 0.03%
3,249,994
BKR icon
487
Baker Hughes
BKR
$61.1B
$16.1M 0.03%
472,402
+63,600
+16% +$2.17M
SYRS
488
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$16.1M 0.03%
2,071,914
+1,350,000
+187% +$4.62M
ARDX icon
489
Ardelyx
ARDX
$997M
$16.1M 0.03%
2,600,000
+300,000
+13% +$1.35M
F icon
490
Ford
F
$55.7B
$16.1M 0.03%
1,319,500
-1,089,200
-45% -$12.1M
TAP icon
491
Molson Coors Class B
TAP
$8.09B
$16M 0.03%
261,836
+77,300
+42% +$4.65M
GKOS icon
492
Glaukos
GKOS
$10.6B
$15.9M 0.03%
200,000
-250,000
-56% -$17M
VSTS icon
493
Vestis
VSTS
$1.88B
$15.9M 0.03%
+750,000
New +$12.9M
VRNS icon
494
Varonis Systems
VRNS
$5B
$15.8M 0.03%
+350,000
New +$13.2M
RNR icon
495
RenaissanceRe
RNR
$13.4B
$15.7M 0.03%
+80,000
New +$16.6M
VC icon
496
Visteon
VC
$2.78B
$15.6M 0.03%
125,000
+45,000
+56% +$5.56M
NE icon
497
Noble Corp
NE
$6.51B
$15.6M 0.03%
323,584
-574,999
-64% -$26.9M
EXE
498
Expand Energy Corp
EXE
$21.5B
$15.5M 0.03%
200,812
-235,000
-54% -$19.3M
ESS icon
499
Essex Property Trust
ESS
$18.5B
$15.4M 0.03%
+62,300
New +$13.7M
CMPX icon
500
Compass Therapeutics
CMPX
$387M
$15.4M 0.03%
9,880,000
+3,500,000
+55% +$6.06M

Similar funds

Adage Capital Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Adage Capital Partners held 973 positions worth $48.3B, up 9.5% from $44.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Adage Capital Partners's Q4 2023 filing shows 114 new, 273 increased, 385 reduced and 131 closed positions. Its largest new stake was Uber: 2,148,900 shares worth $132M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q4 2023 buy was Uber: 2,148,900 shares worth $132M.
  • Adage Capital Partners added most to Hess in Q4 2023, an estimated $516M increase.
  • Adage Capital Partners's biggest Q4 2023 reduction was lululemon athletica, cutting an estimated $124M.
  • Adage Capital Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $340M.
  • Adage Capital Partners's ten largest holdings make up 25% of its $48.3B portfolio in Q4 2023.
  • Adage Capital Partners opened 114 new positions and closed 131 in Q4 2023.
  • Adage Capital Partners's portfolio value rose 9.5% quarter-over-quarter to $48.3B.

Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.